SCORING CATHETER WITH DRUG DELIVERY MEMBRANE

• US 20090105687A1
• Filed: 09/26/2008
• Published: 04/23/2009
• Est. Priority Date: 10/05/2007
• Status: Abandoned Application

• Current Assignee: Angioscore Incorporated (Koninklijke Philips N.V.)
• Original Assignee: Angioscore Incorporated (Koninklijke Philips N.V.)
• Inventors: Gerbi, Craig, Deckman, Robert K., Placek, Brian, Munrow, Michael A.
• Application Number:
  US12/239,636
• Publication Number:
  US 20090105687A1
• Time in Patent Office: Days
• US Class Current: 604/509
• CPC Class Codes: A61B 17/320725 with radially expandable cutting or abrading elements A61B17/32075 takes precedence
• CPC Class Codes: A61B 2017/22061 for spreading elements apart
• CPC Class Codes: A61M 2025/105 having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• CPC Class Codes: A61M 2025/1081 having sheaths or the like for covering the balloon but not forming a permanent part of the balloon, e.g. retractable, dissolvable or tearable sheaths
• CPC Class Codes: A61M 2025/1086 having a special balloon surface topography, e.g. pores, protuberances, spikes or grooves
• CPC Class Codes: A61M 25/104 used for angioplasty
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system

Abstract

Angioplasty and other dilatation devices are provided with scoring elements. The device additionally incorporates a separate drug application membrane which is used to deliver drugs and other active substances to a body lumen, typically a blood vessel. The device functions to release drug into a region of the luminal wall as the scoring structure is radially expanded into the lumen wall.

Claims

1. A system for treating a vascular wall, said system comprising:

a catheter including a catheter body having a proximal end and a distal end;

an expandable scoring structure disposed at a distal end of the catheter;

a membrane adapted to be positioned over at least a part of the expandable scoring structure; and

a substance sequestered on or in the membrane, wherein at least a portion of the substance is released from the membrane when the scoring structure is expanded within a body lumen.

2. A system as in claim 1, wherein the expandable scoring structure comprises an inflatable balloon.

3. A system as in claim 2, wherein the expandable scoring structure further comprises a cage disposed over the balloon, wherein the cage opens with the balloon inflation and resiliently closes over the balloon upon deflation.

4. A system as in claim 1, wherein the membrane is disposed at least partially over the cage structure.

5. A system as in claim 1, wherein the membrane is disposed at least partly between the cage structure and the balloon.

6. A system as in claim 1, wherein the membrane has a tubular geometry shaped to be disposed over the expandable scoring structure.

7. A system as in claim 1, wherein the membrane comprises a sheet adapted to be wrapped over the expandable scoring structure.

8. A system as in claim 1, wherein the membrane is elastic so that it expands and contracts as the balloon is inflated and deflated.

9. A system as in claim 1, wherein the membrane is non-distensible or semi-compliant and folded over the balloon before the balloon is inflated.

10. A system as in claim 1, wherein the substance is selected from the group consisting of antiproliferative agents, antimitotic agents, antiplatelet agents, alkylating agents, platinum coordination complexes, hormones, anticoagulants, fibrinolytic agents, antimigratory agents, antisecretory agents, anti-inflammatory agents, indole acetic acids, indene acetic acids, immunosuppressive agents, angiogenic agents, angiotensen receptor blockers, nitric oxide donors, anti-sense oligonucleotides, cell cycle inhibitors, mTOR inhibitors, growth factor receptor signal inhibitors, transduction kinase inhibitors, retenoids, cyclin/CDK inhibitors, HMG co-enzyme reductase inhibitors, protease inhibitors, viral gene vectors, stem cells, in-vivo modified stem cells, macrophages, monoclonal antibodies, paclitaxel, sirulimus, x-ray contrast agents, MRI contrast agents, ultrasound contrast agents, chromogenic dyes, fluorescent dyes, and luminescent dyes.

11. A system as in claim 10, wherein the substance is present in a biodegradable or bioresorbable matrix selected from the group consisting of polymeric nanoparticles and polymeric microparticles.

12. A system as in claim 1, wherein the membrane comprises a polymer.

13. A system as in claim 12, wherein the polymer is selected from the group consisting of Pebax, polyurethane, rubber, polysulfone, nylon 11, nylon 12, ethylene-vinyl acetate copolymers, ethylene-acrylate ester copolymers, vinylpyrrolidone-vinyl acetate, styrene acrylic polymer, ethylene acrylic acid copolymer, carboxyl function acrylic polymer, hydroxyl function acrylic polymer, acrylic dispersion polymer, poly(glycol methacrylate), poly(methyl methacrylate), poly(ethyl methacrylate), poly(butyl methacrylate), poly(sulfanato ethyl methacrylate), poly(ethylene-co-vinyl acetate), poly(ethyl acrylate), poly(urethane-acrylate), poly(acrylamide-co-ethyl methacrylate), poly(divinyl benzene), poly(triethylene glycol-co-divinyl ether), poly(tri-methylol propane triacrylate), poly(pentaerythritol tetraacrylate), poly(bisphenol A ethoxylate diacrylate), poly(allyl ether), poly(diallyl maleate), poly(vinylidene fluoride), poly(triallyl isocyanurate), poly vinyl alcohol, ethylene vinyl alcohol copolymer, collagen, polyethylene, poly ethylene oxide, and polyhydroxyalkanoate.

14. A system as in claim 11, wherein the polymer matrix is permeable and the substance is absorbed therein.

15. A system as in claim 11, wherein the substance is coated on a surface of the membrane.

16. A system as in claim 11, wherein the polymer is dissolvable in the vascular environment.

17. A system as in claim 15, wherein the drug is dispersed within the polymer and released as the polymer dissolves in the vascular environment.

18. A method for treating a luminal wall, said method comprising:

positioning an expandable scoring structure at a treatment site in a body lumen of a patient;

expanding the scoring structure so that said scoring structure scores a region of or on the luminal wall; and

releasing a substance into the scored material from a membrane disposed as least partially over the expandable scoring structure.

19. A method as in claim 18, wherein the scoring structure scores occlusive material on a vascular wall so that the substance is released into the occlusive material.

20. A method as in claim 18, wherein the scoring structure scores the vascular wall so that the substance is released into the vascular wall.

21. A method as in claim 18, wherein the substance is selected from the group consisting of antiproliferative agents, antimitotic agents, antiplatelet agents, alkylating agents, platinum coordination complexes, hormones, anticoagulants, fibrinolytic agents, antimigratory agents, antisecretory agents, anti-inflammatory agents, indole acetic acids, indene acetic acids, immunosuppressive agents, angiogenic agents, angiotensen receptor blockers, nitric oxide donors, anti-sense oligonucleotides, cell cycle inhibitors, mTOR inhibitors, growth factor receptor signal inhibitors, transduction kinase inhibitors, retenoids, cyclin/CDK inhibitors, HMG co-enzyme reductase inhibitors, protease inhibitors, viral gene vectors, stem cells, in-vivo modified stem cells, macrophages, monoclonal antibodies, paclitaxel, sirulimus, x-ray contrast agents, MRI contrast agents, ultrasound contrast agents, chromogenic dyes, fluorescent dyes, and luminescent dyes.

22. A method as in claim 18, wherein expanding comprises inflating a balloon having a scoring cage thereon.

23. A method as in claim 22, wherein the membrane is disposed over the scoring cage.

24. A method as in claim 22, wherein the membrane is disposed between the scoring cage and the balloon.